University of Michigan
Investigators last month published early results, which they believe have set a solid foundation for the independent value of their novel signature.
Abbott Test Can Be Used to Predict Death, Disability for Patients With TBI, Study Finds
The researchers studied the value of testing patients with traumatic brain injury for the GFAP and UCH-L1 markers using Abbott Labs' point-of-care i-STAT Alinity System.
The test measures changes in wavelength to quantify the presence of disease in a patient sample in about 40 minutes.
RenalytixAI, Academic Partners to Monitor Chronic Kidney Disease in Recovered COVID-19 Patients
The London-based firm hopes to also show the clinical utility of its KidneyIntelX assay for predicting the risk of the patients' progressive kidney decline.
RenalytixAI Inks Kidney Disease Dx Deals With University of Michigan, Global Pharmaceutical Firm
RenalytixAI's flagship product is KidneyIntelX, which applies artificial intelligence to patient data to aid in the treatment of progressive kidney disease.
Apr 24, 2018
Dec 20, 2017